17A-羟基孕酮己酸酯

17A-羟基孕酮己酸酯（CAS 630-56-8）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Pharmaceuticals -> Animal Drugs -> Approved in TaiwanHydroxyprogesterone caproate was previously indicated in the US for the prevention of spontaneous preterm births in singleton pregnancies in women with a history of spontaneous preterm birth. This indication was revoked by the FDA in April 2023. Hydroxyprogesterone caproate remains indicated in other jurisdictions for the management of primary and secondary amenorrhea, corpus luteum insufficiency, and for the prevention of preterm birth.

同义词与商品名

HYDROXYPROGESTERONE CAPROATE; 630-56-8; Delalutin; Primolut Depot; Hydroxyprogesterone hexanoate; Hormofort; Syngynon; Proluton Depot; Depo-Proluton; Teralutil; Hylutin; Makena; Pharlon; 17alpha-Hydroxyprogesterone caproate; Procyte depo; NSC-17592

GHS 危害分类

Reported hazard statements	H360 (93.2%)

H360 (93.2%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

公开数据库对它的描述

17A-hydroxyprogesterone hexanoate · CAS 630-56-8 · C27H40O4. UNII 276F2O42F5. Melting Point: 119-121.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。